Versant Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
Versant Capital Management's RIGL Position: Q3 2026 in Review
Versant Capital Management held its Rigel Pharmaceuticals (RIGL) position steady in Q3 2026 at 266 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.
Versant Capital Management first reported a position in RIGL in Q4 2024 and has held it in 8 quarters since. 151 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- Versant Capital Management held 266 shares of Rigel Pharmaceuticals worth $12.8K as of Q3 2026.
- Versant Capital Management left its Rigel Pharmaceuticals share count unchanged in Q3 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2170 holding.
- Versant Capital Management first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- 151 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.